Skip to main content
SpringerLink
Log in

Human Herpesviruses: Herpes Simplex Virus Types 1 and 2

  • Chapter
  • First Online:
Viral Infections of Humans

Abstract

Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) cause a variety of illnesses depending on the site of inoculation (e.g., skin, eye, genital, or oral mucosa), immune status of the host (e.g., immune competent, immune immature, or immunocompromised), and whether the infection is primary or recurrent. HSV infections are ubiquitous, occur throughout the year, and are transmitted person to person through skin-to-skin contact. Most HSV infections are asymptomatic. Primary HSV infections, including those that are asymptomatic, result in the establishment of a lifelong latent infection which causes subsequent recurrent infections. Recurrent infections, particularly asymptomatic recurrences, are principally responsible for the transmission of the viruses to susceptible individuals. Orolabial and genital HSV infections are the most prevalent HSV infections, and orolabial infections are predominantly caused by HSV-1, while genital herpes maybe caused by either virus. Both HSV-1 and HSV-2 prevalence are greater in resource-limited settings. HSV-1 infection is more prevalent with risk of acquisition beginning in infancy and early childhood while HSV-2 is principally a sexually transmitted pathogen, with increasing prevalence of infection seen in sexually experienced people beginning in adolescence. risk of infection is seen in sexually experienced people beginning in adolescence. While HSV infections are significant public health problems in and of themselves, genital HSV-2 infection is particularly problematic as it is associated with a two- to threefold increased risk for HIV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beswick TS. The origin and the use of the word herpes. Med Hist. 1962;6:214–32.

    PubMed  CAS  PubMed Central  Google Scholar 

  2. Nahamias AJ, Dowdle WR. Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol. 1968;10:110–59.

    Google Scholar 

  3. Schneweis KE. Serologische untersuchungen zur Typen-differenzierung des Herpesvirus hominis. Immunitaetsforsch Exp Ther. 1962;124:24–48.

    CAS  Google Scholar 

  4. Plummer G. Serological comparison of the herpes viruses. Br J Exp Pathol. 1964;45:135–41.

    PubMed  CAS  PubMed Central  Google Scholar 

  5. Buchman TG, Simpson T, Nosal C, Roizman B, Nahmias AJ. The structure of herpes simplex virus dna and its application to molecular epidemiology. Ann N Y Acad Sci. 1980;354:279–90.

    PubMed  CAS  Google Scholar 

  6. Pellett PE, Roizman B. The family herpesviridae. A brief introduction. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.

    Google Scholar 

  7. Davison AJ. Evolution of sexually transmitted and sexually transmissible human herpesviruses. Ann N Y Acad Sci. 2011;1230:E37–49.

    PubMed  Google Scholar 

  8. Davison AJ. Herpesvirus systematics. Vet Microbiol. 2010;143:52–69.

    PubMed  CAS  PubMed Central  Google Scholar 

  9. Black FL. Infectious diseases in primitive societies. Science. 1975;187:515–8.

    PubMed  CAS  Google Scholar 

  10. Norberg P, Tyler S, Severini A, Whitley R, Liljeqvist JA, Bergstrom T. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One. 2011;6:e22527.

    PubMed  CAS  PubMed Central  Google Scholar 

  11. Gentry GA, Lowe M, Alford G, Nevins R. Sequence analyses of herpesviral enzymes suggest an ancient origin for human sexual behavior. Proc Natl Acad Sci. 1988;85:2658–61.

    PubMed  CAS  PubMed Central  Google Scholar 

  12. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847–54.

    PubMed  CAS  Google Scholar 

  13. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;316:1444–9.

    PubMed  CAS  Google Scholar 

  14. Yoshikawa T, Hill JM, Stanberry LR, Bourne N, Kurawadwala JF, Krause PR. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med. 1996;184:659–64.

    PubMed  CAS  Google Scholar 

  15. Teh CZ, Sacks SL. Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2′-deoxyuridine: preferential inhibition of herpes simplex virus type 2. Antimicrob Agents Chemother. 1983;23:637–40.

    PubMed  CAS  PubMed Central  Google Scholar 

  16. Johnston C, Morrow RA, Moreland A, Wald A. Genital herpes. In: Morse SA, Holmes KK, Ballard RC, Moreland AA, editors. Atlas of sexually transmitted diseases and AIDS 4th ed. Netherlands: Elsevier; 2010. p. 169–85.

    Google Scholar 

  17. Turner R, Shehab Z, Osborne K, Hendley JO. Shedding and survival of herpes simplex virus from ‘fever blisters’. Pediatrics. 1982;70:547–49.

    PubMed  CAS  Google Scholar 

  18. Nerurkar LS, West F, May M, Madden DL, Sever JL. Survival of herpes simplex virus in water specimens collected from hot tubs in spa facilities and on plastic surfaces. JAMA. 1983;250:3081–3.

    PubMed  CAS  Google Scholar 

  19. Asculai SS, Weis MT, Rancourt MW, Kupferberg AB. Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother. 1978;13:686–90.

    PubMed  CAS  PubMed Central  Google Scholar 

  20. Boss IW, Renne R. Viral miRNAs and immune evasion. Biochim Biophys Acta. 2011;1809:708–14.

    PubMed  CAS  Google Scholar 

  21. Horst D, Ressing ME, Wiertz EJ. Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls. Immunol Cell Biol. 2011;89:359–66.

    PubMed  CAS  Google Scholar 

  22. Stanberry LR. Pathogenesis of herpes simplex virus infection and animal models for its study. Curr Top Microbiol Immunol. 1992;179:15–30.

    PubMed  CAS  Google Scholar 

  23. Kern ER. Animal models for central nervous system and disseminated infections with herpes simplex virus. In: Zak O, Sande M, editors. Handbook of animal models of infection. London: Academic; 1999. p. 899–906.

    Google Scholar 

  24. Bourne N, Stanberry LR. Animal models of herpesvirus genital infection: guinea pig. In: Zak O, Sande M, editors. Handbook of animal models of infection. London: Academic; 1999.

    Google Scholar 

  25. McKeough MB, Spruance SL. Animal models of herpes skin infection: guinea-pig. In: Zak O, Sande M, editors. Handbook of animal models of infection. London: Academic; 1999. p. 911–8.

    Google Scholar 

  26. Gebhardt BM, Varnell ED, Hill JM, Kaufman HE. Animal models of ocular herpes simplex virus infection (rabbits, primates, mice). In: Zak O, Sande M, editors. Handbook of animal models of infection. London: Academic; 1999. p. 919–26.

    Google Scholar 

  27. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med. 1999;341:1432–8.

    PubMed  CAS  Google Scholar 

  28. Manservigi R, Cassai E. The glycoproteins of the human herpesviruses. Comp Immunol Microbiol Infect Dis. 1991;14:81–95.

    PubMed  CAS  Google Scholar 

  29. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 2501–602.

    Google Scholar 

  30. Campadelli-Fiume G, Menotti L, Avitabile E, Gianni T. Viral and cellular contributions to herpes simplex virus entry into the cell. Curr Opin Virol. 2012;2:28–36.

    PubMed  CAS  Google Scholar 

  31. Ashley R, Mertz G, Clark H, Schick M, Salter D, Corey L. Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine. J Virol. 1985;56:475–81.

    PubMed  CAS  PubMed Central  Google Scholar 

  32. Bernstein DI, Bryson YJ, Lovett MA. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol. 1985;15:251–63.

    PubMed  CAS  Google Scholar 

  33. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988;26:662–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  34. Ashley RL, Dalessio J, Dragavon J, et al. Underestimation of HSV-2 seroprevalence in a high-risk population by microneutralization assay. Sex Transm Dis. 1993;20:230–5.

    PubMed  CAS  Google Scholar 

  35. Golden MR, Ashley-Morrow R, Swenson P, Hogrefe WR, Handsfield HH, Wald A. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Transm Dis. 2005;32:771–7.

    PubMed  Google Scholar 

  36. Gopal R, Gibbs T, Slomka MJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods. 2000;87:71–80.

    PubMed  CAS  Google Scholar 

  37. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DW. Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay. J Virol Methods. 1995;55:27–35.

    PubMed  CAS  Google Scholar 

  38. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337:1105–11.

    PubMed  CAS  Google Scholar 

  39. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296:964–73.

    PubMed  CAS  Google Scholar 

  40. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis. 2002;185:1019–24.

    PubMed  Google Scholar 

  41. Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol. 2001;153:912–20.

    PubMed  CAS  Google Scholar 

  42. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80:185–91.

    PubMed  CAS  PubMed Central  Google Scholar 

  43. Morrow RA, Friedrich D, Meier A, Corey L. Use of “biokit HSV-2 Rapid Assay” to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infect Dis. 2005;5:84.

    PubMed  PubMed Central  Google Scholar 

  44. Reddy SM, Balakrishnan P, Uma S, Thyagarajan SP, Solomon S. Performance of Two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies. Clin Diagn Lab Immunol. 2005;12:359–60.

    PubMed  CAS  PubMed Central  Google Scholar 

  45. Van Dyck E, Buvé A, Weiss HA, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol. 2004;42:2961–5.

    PubMed  PubMed Central  Google Scholar 

  46. Hogrefe WR, Ernst C, Su X. Efficiency of reconstitution of immunoglobulin G from blood specimens dried on filter paper and utility in herpes simplex virus type-specific serology screening. Clin Diagn Lab Immunol. 2002;9:1338–42.

    PubMed  CAS  PubMed Central  Google Scholar 

  47. Ashley RL, Wald A, Eagleton M. Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [see comment]. Sex Transm Dis. 2000;27:266–9.

    PubMed  CAS  Google Scholar 

  48. Delany-Moretlwe S, Jentsch U, Weiss H, et al. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population. Sex Transm Infect. 2010;86:46–50.

    PubMed  Google Scholar 

  49. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186 Suppl 1:S3–28.

    PubMed  Google Scholar 

  50. Biraro S, Mayaud P, Morrow RA, Grosskurth H, Weiss HA. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Dis. 2011;38:140–7.

    PubMed  CAS  Google Scholar 

  51. Mujugira A, Morrow RA, Celum C, et al. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sex Transm Infect. 2011;87:238–41.

    PubMed  PubMed Central  Google Scholar 

  52. Lingappa J, Nakku-Joloba E, Magaret A, et al. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans. Int J STD AIDS. 2010;21:611–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  53. Morrow RA, Friedrich D, Krantz E. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes. J Clin Microbiol. 2003;41:5212–4.

    PubMed  CAS  PubMed Central  Google Scholar 

  54. Gamiel JL, Tobian AAR, Laeyendecker OB, et al. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin Vaccine Immunol. 2008;15:888–90.

    PubMed  CAS  PubMed Central  Google Scholar 

  55. Koutsky LA, Ashley RL, Holmes KK, et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis. 1990;17:90–4.

    PubMed  CAS  Google Scholar 

  56. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770–5.

    PubMed  CAS  Google Scholar 

  57. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59:1–110.

    PubMed  Google Scholar 

  58. Morrow R, Friedrich D. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection. Clin Microbiol Infect. 2006;12:463–9.

    PubMed  CAS  Google Scholar 

  59. Morrow RA, Friedrich D, Krantz E, Wald A. Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G. Sex Transm Dis. 2004;31:508–15.

    PubMed  CAS  Google Scholar 

  60. Cypress CFT. HerpeSelect 1 ELISA IgG 2005. Cypress: Focus Technologies; 2005.

    Google Scholar 

  61. Xu F, Lee FK, Morrow RA, et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr. 2007;151:374–7.

    PubMed  Google Scholar 

  62. Jensen C, Johnson FB. Comparison of various transport media for viability maintenance of herpes simplex virus, respiratory syncytial virus, and adenovirus. Diagn Microbiol Infect Dis. 1994;19:137–42.

    PubMed  CAS  Google Scholar 

  63. Jerome KR, Morrow RA. Herpes simplex viruses and herpes B virus. In: Landry M, editor. Manual of clinical microbiology. 10th ed. Washington, DC: ASM Press; 2010. p. 1530–44.

    Google Scholar 

  64. Crist GA, Langer JM, Woods GL, Procter M, Hillyard DR. Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens. Diagn Microbiol Infect Dis. 2004;49:173–7.

    PubMed  CAS  Google Scholar 

  65. Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188:1345–51.

    PubMed  CAS  Google Scholar 

  66. Espy MJ, Uhl JR, Mitchell PS, et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol. 2000;38:795–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  67. Corey L, Huang M-L, Selke S, Wald A. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol. 2005;76:350–5.

    PubMed  CAS  Google Scholar 

  68. Van Der Pol B, Warren T, Taylor SN, et al. Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol. 2012;50:3466–71.

    Google Scholar 

  69. Mertz KJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis. 1998;178:1795–8.

    PubMed  CAS  Google Scholar 

  70. Bruisten SM, Cairo I, Fennema H, et al. Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol. 2001;39:601–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  71. Nilsen A, Kasubi MJ, Mohn SC, Mwakagile D, Langeland N, Haarr L. Herpes simplex virus infection and genital ulcer disease among patients with sexually transmitted infections in Dar es Salaam, Tanzania. Acta Derm Venereol. 2007;87:355–9.

    PubMed  Google Scholar 

  72. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17:1–13.

    PubMed  PubMed Central  Google Scholar 

  73. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303–27.

    PubMed  CAS  Google Scholar 

  74. Ghebrekidan H, Ruden U, Cox S, Wahren B, Grandien M. Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol. 1999;12:53–64.

    PubMed  CAS  Google Scholar 

  75. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010. J Infect Dis. 2014;209:325–33.

    Google Scholar 

  76. Haddow LJ, Dave B, Mindel A, et al. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex Transm Infect. 2006;82:255–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  77. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect. 2009;85:416–9.

    PubMed  CAS  Google Scholar 

  78. Tran T, Druce JD, Catton MC, Kelly H, Birch CJ. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex Transm Infect. 2004;80:277–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  79. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003;30:797–800.

    PubMed  Google Scholar 

  80. Moss N, Harper C, Ahrens K, et al. Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco. BMC Infect Dis. 2007;7:113.

    PubMed  PubMed Central  Google Scholar 

  81. Gottlieb SL, Douglas Jr JM, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis. 2004;190:1059–67.

    PubMed  Google Scholar 

  82. Page WF, Chubb M, Feng X, et al. National estimates of seroincidence and seroprevalence for herpes simplex virus type 1 and type 2 among US Military adults aged 18 to 29 years. Sex Transm Dis. 2012;39:241–50. doi:10.1097/OLQ.0b013e3182401a17.

    PubMed  Google Scholar 

  83. Stanberry LR, Rosenthal SL, Mills L, et al. Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis. 2004;39:1433–8.

    PubMed  Google Scholar 

  84. Mugo N, Dadabhai SS, Bunnell R, et al. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya. Sex Transm Dis. 2011;38:1059–66. doi:10.1097/OLQ.0b013e31822e60b6.

    PubMed  Google Scholar 

  85. Mehta SD, Moses S, Agot K, et al. Herpes simplex virus type 2 infection among young uncircumcised men in Kisumu, Kenya. Sex Transm Infect. 2008;84:42–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  86. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86:805–12, A.

    PubMed  PubMed Central  Google Scholar 

  87. Abu-Raddad LJ, Schiffer JT, Ashley R, et al. HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics. 2010;2:173–82.

    PubMed  PubMed Central  Google Scholar 

  88. Biswas D, Borkakoty B, Mahanta J, et al. Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC Infect Dis. 2011;11:325.

    PubMed  PubMed Central  Google Scholar 

  89. Center for Disease Control and Prevention. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years – United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2010;59:456–9.

    Google Scholar 

  90. Gottlieb SL, Douglas Jr JM, Schmid DS, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis. 2002;186:1381–9.

    PubMed  Google Scholar 

  91. Patel P, Bush T, Mayer KH, et al. Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis. 2012;39:154–60.

    PubMed  Google Scholar 

  92. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis. 2000;182:1090–6.

    PubMed  CAS  Google Scholar 

  93. Lama JR, Lucchetti A, Suarez L, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis. 2006;194:1459–66.

    PubMed  Google Scholar 

  94. Gwanzura L, McFarland W, Alexander D, Burke RL, Katzenstein D. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998;177:481–4.

    PubMed  CAS  Google Scholar 

  95. Boulos R, Ruff AJ, Nahmias A, et al. Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type I infections. The Johns Hopkins University (JHU)/Centre pour le Developpement et la Sante (CDS) HIV Study Group. J Infect Dis. 1992;166:418–20.

    PubMed  CAS  Google Scholar 

  96. Mertz KJ, Weiss JB, Webb RM, et al. An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis. 1998;178:1060–6.

    PubMed  CAS  Google Scholar 

  97. Paz-Bailey G, Rahman M, Chen C, et al. Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin Infect Dis. 2005;41:1304–12.

    PubMed  Google Scholar 

  98. Mwansasu A, Mwakagile D, Haarr L, Langeland N. Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania. J Clin Virol. 2002;24:183–92.

    PubMed  CAS  Google Scholar 

  99. Lewis DA, Müller E, Steele L, et al. Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa. Sex Transm Dis. 2012;39:880–5. doi:10.1097/OLQ.0b013e318269cf90.

    PubMed  Google Scholar 

  100. Beyrer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis. 1998;178:243–6.

    PubMed  CAS  Google Scholar 

  101. Lai W, Chen CY, Morse SA, et al. Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sex Transm Infect. 2003;79:202–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  102. Report of the expert consultation and review of the latest evidence to update guidelines for the management of sexually transmitted infections. 2011. Available at: http://apps.who.int/iris/bitstream/10665/75194/1/WHO_RHR_11.37_eng.pdf. Accessed 11 Dec 2012.

  103. Prevention CfDCa. 2010 Sexually transmitted disease surveillance. Figure 52 Genital Herpes-initial visits to physicians’ offices, United States, 1966-2010. 2010.

    Google Scholar 

  104. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958–72.

    PubMed  CAS  Google Scholar 

  105. Johnston C, Magaret A, Selke S, Remington M, Corey L, Wald A. Herpes simplex virus viremia during primary genital infection. J Infect Dis. 2008;198:31–4.

    PubMed  Google Scholar 

  106. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med. 1999;131:14–20.

    PubMed  CAS  Google Scholar 

  107. Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis. 2003;30:174–7.

    PubMed  Google Scholar 

  108. Quinn TC, Corey L, Chaffee RG, Schuffler MD, Brancato FP, Holmes KK. The etiology of anorectal infections in homosexual men. Am J Med. 1981;71:395–406.

    PubMed  CAS  Google Scholar 

  109. Goodell SE, Quinn TC, Mkrtichian E, Schuffler MD, Holmes KK, Corey L. Herpes simplex virus proctitis in homosexual men. N Engl J Med. 1983;308:868–71.

    PubMed  CAS  Google Scholar 

  110. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350:11–20.

    PubMed  CAS  Google Scholar 

  111. Bernstein DI, Bellamy AR, Hook EW, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56:344–51.

    Google Scholar 

  112. Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305:1439–44.

    PubMed  CAS  Google Scholar 

  113. Bagdades EK, Pillay D, Squire SB, O’Neil C, Johnson MA, Griffiths PD. Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. Aids. 1992;6:1317–20.

    PubMed  CAS  Google Scholar 

  114. Yudin MH, Kaul R. Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy. Infect Dis Obstet Gynecol. 2008;2008:592532.

    Google Scholar 

  115. Samaratunga H, Weedon D, Musgrave N, McCallum N. Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology. 2001;33:532–5.

    PubMed  CAS  Google Scholar 

  116. Nadal SR, Calore EE, Manzione CR, Horta SC, Ferreira AF, Almeida LV. Hypertrophic herpes simplex simulating anal neoplasia in AIDS patients: report of five cases. Dis Colon Rectum. 2005;48:2289–93.

    PubMed  Google Scholar 

  117. Fangman WL, Rao CH, Myers SA. Hypertrophic herpes simplex virus in HIV patients. J Drugs Dermatol. 2003;2:198–201.

    PubMed  Google Scholar 

  118. Cury K, Valin N, Gozlan J, et al. Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient. Sex Transm Dis. 2010;37:126–8.

    PubMed  Google Scholar 

  119. Reyes M, Shaik NS, Graber JM, et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med. 2003;163:76–80.

    PubMed  Google Scholar 

  120. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol. 2004;42:242–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  121. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after Two decades of antiviral therapy. Clin Microbiol Rev. 2003;16:114–28.

    PubMed  CAS  PubMed Central  Google Scholar 

  122. Erard V, Wald A, Corey L, Leisenring W, Boeckh M. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease. J Infect Dis. 2007;196:266–70.

    PubMed  CAS  Google Scholar 

  123. Amir J, Harel L, Smetana Z, Varsano I. The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatr Dermatol. 1999;16:259–63.

    PubMed  CAS  Google Scholar 

  124. Harel L, Smetana Z, Prais D, et al. Presence of viremia in patients with primary herpetic gingivostomatitis. Clin Infect Dis. 2004;39:636–40.

    PubMed  Google Scholar 

  125. Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol. 1976;41:498–507.

    PubMed  CAS  Google Scholar 

  126. Rooney JF, Mannix ML, Wohlenberg CR, et al. Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet. 1991;338:1419–22.

    PubMed  CAS  Google Scholar 

  127. Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998—2000. Clin Infect Dis. 2003;36:731–42.

    PubMed  Google Scholar 

  128. Granerod J, Ambrose HE, Davies NWS, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835–44.

    PubMed  Google Scholar 

  129. Whitley RJ, Soong S, Linneman C, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis: clinical assessment. JAMA. 1982;247:317–20.

    PubMed  CAS  Google Scholar 

  130. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006;71:141–8.

    PubMed  CAS  Google Scholar 

  131. Hjalmarsson A, Blomqvist P, Sköldenberg B. Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis. 2007;45:875–80.

    PubMed  Google Scholar 

  132. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314:144–9.

    PubMed  CAS  Google Scholar 

  133. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995;171:857–63.

    Google Scholar 

  134. Shyu WC, Lin JC, Chang BC, Harn HJ, Lee CC, Tsao W-L. Recurrent ascending myelitis: an unusual presentation of herpes simplex virus type 1 infection. Ann Neurol. 1993;34:625–7.

    PubMed  CAS  Google Scholar 

  135. Klastersky J, Cappel R, Snoeck JM, Flament J, Thiry L. Ascending myelitis in association with herpes-simplex virus. N Engl J Med. 1972;287:182–4.

    PubMed  CAS  Google Scholar 

  136. Picard FJ, Dekaban GA, Silva J, Rice GP. Mollaret’s meningitis associated with herpes simplex type 2 infection. Neurology. 1993;43:1722–7.

    PubMed  CAS  Google Scholar 

  137. Aurelius E, Forsgren M, Gille E, Sköldenberg B. Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scand J Infect Dis. 2002;34:278–83.

    PubMed  Google Scholar 

  138. Aurelius E, Franzen-Röhl E, Glimåker M, et al. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis. 2012;54:1304–13.

    PubMed  CAS  Google Scholar 

  139. Mori I. ‘Spontaneous molecular reactivation’ of herpes simplex virus type 1 in the brain as a pathogenic mechanism of Alzheimer’s disease. Med Hypotheses. 2011;77:463.

    PubMed  Google Scholar 

  140. Ball MJ. Limbic prediliction in Alzheimer dementia: is reactivated herpesvirus involved? Can J Neurol Sci. 1982;9:303–6.

    PubMed  CAS  Google Scholar 

  141. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997;349:241–4.

    PubMed  CAS  Google Scholar 

  142. Lin WR, Graham J, MacGowan SM, Wilcock GK, Itzhaki RF. Alzheimer’s disease, herpes virus in brain, apolipoprotein E4 and herpes labialis. Alzheimers Rep. 1998;1:173–8.

    Google Scholar 

  143. Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A. APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex Transm Infect. 2010;86:202–6.

    PubMed  PubMed Central  Google Scholar 

  144. Burgos JS, Ramirez C, Sastre I, Valdivieso F. Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J Virol. 2006;80:5383–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  145. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular [beta]-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429:95–100.

    PubMed  CAS  Google Scholar 

  146. De Chiara G, Marcocci ME, Civitelli L, et al. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One. 2010;5:e13989.

    PubMed  PubMed Central  Google Scholar 

  147. Wozniak M, Frost AL, Itzhaki RF. Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16:341–50.

    PubMed  CAS  Google Scholar 

  148. Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of Key Alzheimer’s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One. 2011;6:e25152.

    PubMed  CAS  PubMed Central  Google Scholar 

  149. Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol. 2009;217:131–8.

    PubMed  CAS  Google Scholar 

  150. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20:1–13.

    PubMed  CAS  Google Scholar 

  151. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex: Incidence in Rochester, MN, 1950 through 1982. Arch Ophthalmol. 1989;107:1155–9.

    PubMed  CAS  Google Scholar 

  152. Wishart MS, Darougar S, Viswalingam ND. Recurrent herpes simplex virus ocular infection: epidemiologic and clinical features. Br J Ophthalmol. 1987;71:669–72.

    PubMed  CAS  PubMed Central  Google Scholar 

  153. Landry ML, Mullangi P, Nee P, Klein BR. Herpes simplex virus type 2 acute retinal necrosis 9 years after neonatal herpes. J Pediatr. 2005;146:836–8.

    PubMed  Google Scholar 

  154. Handsfield HH, Waldo AB, Brown ZA, et al. Neonatal herpes should be a reportable disease. Sex Transm Dis. 2005;32:521–5.

    PubMed  Google Scholar 

  155. Flagg EW, Weinstock H. Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics. 2011;127:e1–8.

    PubMed  Google Scholar 

  156. Handel S, Klingler EJ, Washburn K, Blank S, Schillinger JA. Population-based surveillance for neonatal herpes in New York City, April 2006-September 2010. Sex Transm Dis. 2011;38:705–11.

    PubMed  Google Scholar 

  157. Morris SR, Bauer HM, Samuel MC, Gallagher D, Bolan G. Neonatal herpes morbidity and mortality in California, 1995-2003. Sex Transm Dis. 2008;35:14–8. doi:10.1097/OLQ.0b013e3180f62bc7.

    PubMed  Google Scholar 

  158. Whitley R, Davis EA, Suppapanya N. Incidence of neonatal herpes simplex virus infections in a managed-care population. Sex Transm Dis. 2007;34:704–8. doi:10.1097/01.olq.0000258432.33412.e2.

    PubMed  Google Scholar 

  159. Xu F, Gee JM, Naleway A, et al. Incidence of neonatal herpes simplex virus infections in two managed care organizations: implications for surveillance. Sex Transm Dis. 2008;35:592–8.

    PubMed  Google Scholar 

  160. Dinh T-H, Dunne EF, Markowitz LE, Weinstock H, Berman S. Assessing neonatal herpes reporting in the United States, 2000-2005. Sex Transm Dis. 2008;35:19–21. doi:10.1097/OLQ.0b013e318162c4c6.

    PubMed  Google Scholar 

  161. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics. 2006;117:1955–62.

    PubMed  Google Scholar 

  162. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203–9.

    PubMed  Google Scholar 

  163. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509–15.

    PubMed  CAS  Google Scholar 

  164. APBN. Management of herpes in pregnancy. Obstet Gynecol. 2007;109:1489–98.

    Google Scholar 

  165. Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006;194:774–81.

    PubMed  CAS  Google Scholar 

  166. Sheffield JS, Hill JB, Hollier LM, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol. 2006;108:141–7.

    PubMed  Google Scholar 

  167. Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol. 2003;188:836–43.

    PubMed  CAS  Google Scholar 

  168. Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel Jr GD. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol. 2002;10:71–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  169. Pinninti SG, Angara R, Feja KN, et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. J Pediatr. 2012;161(1):134–8.e1–3.

    PubMed  Google Scholar 

  170. Kimberlin DW, Lin C-Y, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108:223–9.

    PubMed  CAS  Google Scholar 

  171. Kimberlin DW, Lin C-Y, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108:230–8.

    PubMed  CAS  Google Scholar 

  172. Kimberlin DW, Whitley RJ, Wan W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365:1284–92.

    PubMed  CAS  PubMed Central  Google Scholar 

  173. David TJ, Longson M. Herpes simplex infections in atopic eczema. Arch Dis Child. 1985;60:338–43.

    PubMed  CAS  PubMed Central  Google Scholar 

  174. Luca NJC, Lara-Corrales I, Pope E. Eczema herpeticum in children: clinical features and factors predictive of hospitalization. J Pediatr. 2012;161:671–5.

    PubMed  Google Scholar 

  175. Aronson PL, Yan AC, Mittal MK, Mohamad Z, Shah SS. Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum. Pediatrics. 2011;128:1161–7.

    PubMed  PubMed Central  Google Scholar 

  176. Stern H, Elek SD, Millar DM, Anderson HF. Herpetic whitlow, a form of cross-infection in hospitals. Lancet. 1959;2:871–4.

    PubMed  CAS  Google Scholar 

  177. Browning WD, McCarthy JP. A case series: herpes simplex virus as an occupational hazard. J Esthet Restor Dent. 2012;24:61–6.

    PubMed  PubMed Central  Google Scholar 

  178. Gill MJ, Arlette J, Buchan K. Herpes simplex virus infection of the hand. A profile of 79 cases. Am J Med. 1988;84:89–93.

    PubMed  CAS  Google Scholar 

  179. Feder HM, Geller RW. Herpetic whitlow of the great toe. N Engl J Med. 1992;326:1295–6.

    PubMed  Google Scholar 

  180. Egan LJ, Bylander JM, Agerter DC, Edson RS. Herpetic whitlow of the Toe: an unusual manifestation of infection with herpes simplex virus type 2. Clin Infect Dis. 1998;26:196–7.

    PubMed  CAS  Google Scholar 

  181. Anderson BJ. Managing herpes gladiatorum outbreaks in competitive wrestling: the 2007 Minnesota experience. Curr Sports Med Rep. 2008;7:323–7. doi:10.1249/JSR.0b013e31818eebde.

    PubMed  CAS  Google Scholar 

  182. ANDERSON BJ. The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. Med Sci Sports Exerc. 2003;35:1809–14.

    PubMed  Google Scholar 

  183. Aslanzadeh J, Helm KF, Espy MJ, Muller SA, Smith TF. Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol. 1992;126:19–23.

    PubMed  CAS  Google Scholar 

  184. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol. 1993;128:542–5.

    PubMed  CAS  Google Scholar 

  185. Montalbano M, Slapak-Green GI, Neff GW. Fulminant hepatic failure from herpes simplex virus: post liver transplantation acyclovir therapy and literature review. Transplant Proc. 2005;37:4393–6.

    PubMed  CAS  Google Scholar 

  186. Ramsey PG, Fife KH, Hackman RC, Meyers JD, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med. 1982;97:813–20.

    PubMed  CAS  Google Scholar 

  187. Jacques SM, Qureshi F. Herpes simplex virus hepatitis in pregnancy: a clinicopathologic study of three cases. Hum Pathol. 1992;23:183–7.

    PubMed  CAS  Google Scholar 

  188. Allen RH, Tuomala RE. Herpes simplex virus hepatitis causing acute liver dysfunction and thrombocytopenia in pregnancy. Obstet Gynecol. 2005;106:1187–9.

    PubMed  Google Scholar 

  189. Gruson D, Hilbert G, Le Bail B, et al. Fulminant hepatitis due to herpes simplex virus-type 2 in early phase of bone marrow transplantation. Hematol Cell Ther. 1998;40:41–4.

    PubMed  CAS  Google Scholar 

  190. Johnson JR, Egaas S, Gleaves CA, Hackman R, Bowden RA. Hepatitis due to herpes simplex virus in marrow-transplant recipients. Clin Infect Dis. 1992;14:38–45.

    PubMed  CAS  Google Scholar 

  191. Curley MJ, Hussein SA, Hassoun PM. Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. J Clin Microbiol. 2002;40:2302–4.

    PubMed  PubMed Central  Google Scholar 

  192. Miyazaki YAS, Sakaoka H, Yamamoto S, Terao H. Disseminated infection of herpes simplex virus with fulminant hepatitis in a healthy adult. A case report. APMIS. 1991;99:1001–7.

    PubMed  CAS  Google Scholar 

  193. Pinna ADRJ, Demetris AJ, Fung JJ. Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig Dis Sci. 2002;47:750–4.

    PubMed  Google Scholar 

  194. Price TM, Harris JB. Fulminant hepatic failure due to herpes simplex after hysteroscopy. Obstet Gynecol. 2001;98:954–6.

    PubMed  CAS  Google Scholar 

  195. Czartoski T, Liu C, Koelle DM, Schmechel S, Kalus A, Wald A. Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman. J Clin Microbiol. 2006;44:1584–6.

    PubMed  PubMed Central  Google Scholar 

  196. Stanberry LR. Genital and neonatal herpes simplex virus infections: epidemiology, pathogenesis and prospects for control. Rev Med Virol. 1993;3:37–46.

    Google Scholar 

  197. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol. 2011;9:369–81.

    PubMed  CAS  PubMed Central  Google Scholar 

  198. Laquerre S, Argnani R, Anderson DB, Zucchini S, Manservigi R, Glorioso JC. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol. 1998;72:6119–30.

    PubMed  CAS  PubMed Central  Google Scholar 

  199. Navaratnarajah CK, Miest TS, Carfi A, Cattaneo R. Targeted entry of enveloped viruses: measles and herpes simplex virus I. Curr Opin Virol. 2012;2:43–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  200. Smith G. Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol. 2012;66:153–76.

    PubMed  CAS  Google Scholar 

  201. Cook ML, Stevens JG. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun. 1973;7:272–88.

    PubMed  CAS  PubMed Central  Google Scholar 

  202. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis. 2006;194 Suppl 1:S11–8.

    PubMed  CAS  Google Scholar 

  203. Stanberry LR. Capsaicin interferes with the centrifugal spread of virus in primary and recurrent genital herpes simplex virus infections. J Infect Dis. 1990;162:29–34.

    PubMed  CAS  Google Scholar 

  204. Stanberry LR, Bourne N, Bravo FJ, Bernstein DI. Capsaicin-sensitive peptidergic neurons are involved in the zosteriform spread of herpes simplex virus infection. J Med Virol. 1992;38:142–6.

    PubMed  CAS  Google Scholar 

  205. Schmidt OW, Fife KH, Corey L. Reinfection is an uncommon occurrence in patients with symptomatic recurrent genital herpes. J Infect Dis. 1984;149:645–6.

    PubMed  CAS  Google Scholar 

  206. Lakeman AD, Nahmias AJ, Whitley RJ. Analysis of DNA from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion. Sex Transm Dis. 1986;13:61–6.

    PubMed  CAS  Google Scholar 

  207. Roest RW, Maertzdorf J, Kant M, van der Meijden WI, Osterhaus AD, Verjans GM. High incidence of genotypic variance between sequential herpes simplex virus type 2 isolates from HIV-1-seropositive patients with recurrent genital herpes. J Infect Dis. 2006;194:1115–8.

    PubMed  CAS  Google Scholar 

  208. Roest RW, Carman WF, Maertzdorf J, et al. Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. J Med Virol. 2004;73:601–4.

    PubMed  CAS  Google Scholar 

  209. Buchman TG, Roizman B, Nahmias AJ. Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. J Infect Dis. 1979;140:295–304.

    PubMed  CAS  Google Scholar 

  210. Held K, Derfuss T. Control of HSV-1 latency in human trigeminal ganglia—current overview. J Neurovirol. 2011;17:518–27.

    PubMed  Google Scholar 

  211. Roizman B, Zhou G, Du T. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J Neurovirol. 2011;17:512–7.

    PubMed  Google Scholar 

  212. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99:1092–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  213. Krause PR, Stanberry LR, Bourne N, et al. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med. 1995;181:297–306.

    PubMed  CAS  Google Scholar 

  214. Bertke AS, Patel A, Krause PR. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism. J Virol. 2007;81:6605–13.

    PubMed  CAS  PubMed Central  Google Scholar 

  215. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today. 1997;18:443–9.

    PubMed  CAS  Google Scholar 

  216. Stroop WG, Schaefer DC. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J Infect Dis. 1986;153:721–31.

    PubMed  CAS  Google Scholar 

  217. Whitley R, Lakeman AD, Nahmias A, Roizman B. DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982;307:1060–2.

    PubMed  CAS  Google Scholar 

  218. Nahmias AJ, Alford CA, Korones SB. Infection of the newborn with herpesvirus hominis. Adv Pediatr. 1970;17:185–226.

    PubMed  CAS  Google Scholar 

  219. Bravo FJ, Myers MG, Stanberry LR. Neonatal herpes simplex virus infection: pathogenesis and treatment in the guinea pig. J Infect Dis. 1994;169:947–55.

    PubMed  CAS  Google Scholar 

  220. Stanberry LR, Floyd-Reising SA, Connelly BL, et al. Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin Infect Dis. 1994;18:401–7.

    PubMed  CAS  Google Scholar 

  221. Lewensohn-Fuchs I, Österwall P, Forsgren M, Malm G. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J Clin Virol. 2003;26:39–48.

    PubMed  Google Scholar 

  222. Thompson C, Whitley R. Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol. 2011;697:221–30.

    PubMed  PubMed Central  Google Scholar 

  223. Meyers JD, Flournoy N, Thomas ED. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis. 1980;142:338–46.

    PubMed  CAS  Google Scholar 

  224. Quinnan Jr GV, Masur H, Rook AH, et al. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA. 1984;252:72–7.

    PubMed  Google Scholar 

  225. Muller SA, Herrmann Jr EC, Winkelmann RK. Herpes simplex infections in hematologic malignancies. Am J Med. 1972;52:102–14.

    PubMed  CAS  Google Scholar 

  226. Nahamias AJ, Alrod CA, Korones SB. Infection of the newborn with herpesvirus hominis. Adv Pediatr. 1970;17:185–226.

    Google Scholar 

  227. Perppercorn A, Veit LSC, Weber DJ, Jones S, Cairns BA. Overwhelming disseminated herpes simplex virus type 2 infection in a patient with severe burn injury: case report and literature review. J Burn Care Res. 2010;31:492–98.

    Google Scholar 

  228. Nienaber J-HJC, McNamara DR, Banerjee R, Pritt BS, Karre T, Sohail MR. Fulminant gestational hepatitis due to primary herpes simplex type 2 infection: use of serum HSV polymerase chain reaction for noninvasive diagnosis. Diagn Microbiol Infect Dis. 2012;72:181–4.

    PubMed  CAS  Google Scholar 

  229. Jazeron J-F, Barbe C, Frobert E, et al. Virological diagnosis of herpes simplex virus 1 esophagitis by quantitative real-time PCR assay. J Clin Microbiol. 2012;50:948–52.

    PubMed  PubMed Central  Google Scholar 

  230. Whitley RJ, Miller RL. Immunologic approach to herpes simplex virus. Viral Immunol. 2001;14:111–8.

    PubMed  CAS  Google Scholar 

  231. Chan T, Barra NG, Lee AJ, Ashkar AA. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa. J Reprod Immunol. 2011;88:210–8.

    PubMed  CAS  Google Scholar 

  232. Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol. 2011;1:487–96.

    PubMed  CAS  PubMed Central  Google Scholar 

  233. Simmonds P, Smith IW, Peutherer JF. Detection of antibody to viral proteins following primary infection with herpes simplex virus. J Med Virol. 1987;23:191–205.

    PubMed  CAS  Google Scholar 

  234. Liu A, Sanchez-Pescador L, Ruiz-Palacios G, Morrow AL, Pickering LK, Kohl S. A comparison of herpes simplex virus specific antibodies found in human milk and serum. Pediatr Res. 1992;31:591–5.

    PubMed  CAS  Google Scholar 

  235. McDermott MR, Brais LJ, Evelegh MJ. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J Gen Virol. 1990;71(Pt 7):1497–504.

    PubMed  CAS  Google Scholar 

  236. Jordan J, Rytel MW. Detection of herpes simplex virus (HSV) type-1 IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA). Am J Clin Pathol. 1981;76:467–71.

    PubMed  CAS  Google Scholar 

  237. Juto P, Settergren B. Specific serum IgA, IgG and IgM antibody determination by a modified indirect ELISA-technique in primary and recurrent herpes simplex virus infection. J Virol Methods. 1988;20:45–55.

    PubMed  CAS  Google Scholar 

  238. Dudley KL, Bourne N, Milligan GN. Immune protection against HSV-2 in B-cell-deficient mice. Virology. 2000;270:454–63.

    PubMed  CAS  Google Scholar 

  239. Morrison LA, Zhu L, Thebeau LG. Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J Virol. 2001;75:1195–204.

    PubMed  CAS  PubMed Central  Google Scholar 

  240. Li Z, Palaniyandi S, Zeng R, et al. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A. 2011;108:4388–93.

    PubMed  CAS  PubMed Central  Google Scholar 

  241. Yeager AS, Arvin AM, Urbani LJ, Kemp 3rd JA. Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect Immun. 1980;29:532–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  242. Johnston C, Koelle DM, Wald A. HSV-2: in pursuit of a vaccine. J Clin Invest. 2011;121:4600–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  243. Milligan GN, Bernstein DI, Bourne N. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol. 1998;160:6093–100.

    PubMed  CAS  Google Scholar 

  244. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med. 1995;123:845–7.

    PubMed  CAS  Google Scholar 

  245. Safrin S, Ashley R, Houlihan C, Cusick PS, Mills J. Clinical and serologic features of herpes simplex virus infection in patients with AIDS. Aids. 1991;5:1107–10.

    PubMed  CAS  Google Scholar 

  246. Cohen SG, Greenberg MS. Chronic oral herpes simplex virus infection in immunocompromised patients. Oral Surg Oral Med Oral Pathol. 1985;59:465–71.

    PubMed  CAS  Google Scholar 

  247. Shiley K, Blumberg E. Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Infect Dis Clin North Am. 2010;24:373–93.

    PubMed  Google Scholar 

  248. Chentoufi AA, Binder NR, Berka N, et al. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J Virol. 2008;82:11792–802.

    PubMed  CAS  PubMed Central  Google Scholar 

  249. Seppanen M, Meri S, Notkola IL, et al. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. J Infect Dis. 2006;194:571–8.

    PubMed  CAS  Google Scholar 

  250. Zhang S-Y, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317:1522–7.

    PubMed  CAS  Google Scholar 

  251. Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370:2127–37.

    PubMed  Google Scholar 

  252. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342:844–50.

    PubMed  CAS  Google Scholar 

  253. Tronstein E, Johnston C, Huang ML, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305:1441–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  254. Phipps W, Saracino M, Magaret A, et al. Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J Infect Dis. 2011;203:180–7.

    PubMed  PubMed Central  Google Scholar 

  255. Brock BV, Selke S, Benedetti J, Douglas Jr JM, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA. 1990;263:418–20.

    PubMed  CAS  Google Scholar 

  256. Schiffer JT, Wald A, Selke S, Corey L, Magaret A. The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions. J Infect Dis. 2011;204:554–61.

    PubMed  CAS  PubMed Central  Google Scholar 

  257. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197–202.

    PubMed  CAS  Google Scholar 

  258. Schacker T, Zeh J, Hu HL, Hill E, Corey L. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis. 1998;178:1616–22.

    PubMed  CAS  Google Scholar 

  259. Mark KE, Wald A, Magaret AS, et al. Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults. J Acquir Immune Defic Syndr. 2010;54:482–8.

    PubMed  PubMed Central  Google Scholar 

  260. Mark KE, Wald A, Magaret AS, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis. 2008;198:1141–9.

    PubMed  PubMed Central  Google Scholar 

  261. Schiffer JT, Abu-Raddad L, Mark KE, et al. Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. Sci Transl Med. 2009;1:7–16.

    Google Scholar 

  262. Schiffer JT, Abu-Raddad L, Mark KE, et al. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proc Natl Acad Sci U S A. 2010;107:18973–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  263. Tata S, Johnston C, Huang ML, et al. Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa. J Infect Dis. 2010;201:499–504.

    PubMed  PubMed Central  Google Scholar 

  264. Johnston C, Remington M, Zhu J, et al. The pathogenesis of asymptomatic HSV reactivation in the genital tract. 48th annual meeting of the Infectious Diseases Society of America. Vancouver; 2010.

    Google Scholar 

  265. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci. 2005;46:241–7.

    PubMed  PubMed Central  Google Scholar 

  266. Miller CS, Danaher RJ. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:43–50.

    PubMed  Google Scholar 

  267. Kim HN, Meier A, Huang ML, et al. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men. J Infect Dis. 2006;194:420–7.

    PubMed  Google Scholar 

  268. Wald A, Krantz E, Selke S, Lairson E, Morrow RA, Zeh J. Knowledge of partners’ genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis. 2006;194:42–52.

    PubMed  Google Scholar 

  269. Elion GB, Furmah PA, Fyfe JA, De Miranda P, Beauchamp L, Schaeffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxylmethyl)guanine. Proc Natl Acad Sci U S A. 1977;74:5716–20.

    PubMed  CAS  PubMed Central  Google Scholar 

  270. Pasternak BHA. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA. 2010;304:859–66.

    PubMed  CAS  Google Scholar 

  271. Johnson REMJ, Valanis BG, Irwin DE. Utilization and safety of oral acyclovir over an 8-year period. Pharmacoepidemiol Drug Saf. 1997;6:101–13.

    PubMed  CAS  Google Scholar 

  272. Corey L, Benedetti J, Critchlow C, et al. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother. 1983;12 Suppl B:79–88.

    PubMed  CAS  Google Scholar 

  273. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial Canadian Famciclovir Study Group. JAMA. 1996;276:44–9.

    PubMed  CAS  Google Scholar 

  274. Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med. 1996;156:1729–35.

    PubMed  CAS  Google Scholar 

  275. Spruance S, Aoki FY, Tyring S, Stanberry L, Whitley R, Hamed K. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007;56:30–6.

    PubMed  Google Scholar 

  276. Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med. 1984;310:1551–6.

    PubMed  CAS  Google Scholar 

  277. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA. 1988;260:201–6.

    PubMed  CAS  Google Scholar 

  278. Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis. 1998;178:603–10.

    PubMed  CAS  Google Scholar 

  279. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA. 1998;280:887–92.

    PubMed  CAS  Google Scholar 

  280. Sacks SL. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial. J Infect Dis. 2004;189:1341–7.

    PubMed  CAS  Google Scholar 

  281. Patel R, Tyring S, Strand A, Price MJ, Grant DM. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect. 1999;75:398–402.

    PubMed  CAS  PubMed Central  Google Scholar 

  282. Johnston C, Saracino M, Kuntz S, et al. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet. 2012;379:641–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  283. Gilbert SC. Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study. J Drugs Dermatol. 2007;6:400–5.

    PubMed  Google Scholar 

  284. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008;168:1137–44.

    PubMed  CAS  Google Scholar 

  285. Corey L, Fife KH, Benedetti JK, et al. Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med. 1983;98:914–21.

    PubMed  CAS  Google Scholar 

  286. Wilhelmus K. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2008;(1):CD002898.

    Google Scholar 

  287. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med. 1991;325:551–5.

    PubMed  CAS  Google Scholar 

  288. Tyring S, Wald A, Zadeikis N, Dhadda S, Takenouchi K, Rorig R. ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled. Dose-finding study. J Infect Dis. 2012;205(7):1100–10.

    PubMed  CAS  Google Scholar 

  289. Keller MJ, Tuyama A, Carlucci MJ, Herold BC. Topical microbicides for the prevention of genital herpes infection. J Antimicrob Chemother. 2005;55:420–3.

    PubMed  CAS  Google Scholar 

  290. Keller MJ, Malone AM, Carpenter CA, et al. Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring. J Antimicrob Chemother. 2012;67:2005–12.

    PubMed  CAS  PubMed Central  Google Scholar 

  291. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med. 2002;347:1652–61.

    PubMed  CAS  Google Scholar 

  292. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med. 2012;366:34–43.

    PubMed  CAS  PubMed Central  Google Scholar 

  293. Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature. 2012;491:463–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  294. Halford WP, Puschel R, Gershburg E, Wilber A, Gershburg S, Rakowski B. A live-attenuated HSV-2 ICP0(-) virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PLoS One. 2011;6:e17748.

    PubMed  CAS  PubMed Central  Google Scholar 

  295. Brittle EE, Wang F, Lubinski JM, Bunte RM, Friedman HM. A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine. J Virol. 2008;82:8431–41.

    PubMed  CAS  PubMed Central  Google Scholar 

  296. Hoshino Y, Pesnicak L, Dowdell KC, et al. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. J Infect Dis. 2009;200:1088–95.

    PubMed  CAS  Google Scholar 

  297. Brans R, Yao F. Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs. BMC Microbiol. 2010;10:163.

    PubMed  PubMed Central  Google Scholar 

  298. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med. 2009;169:1233–40.

    PubMed  PubMed Central  Google Scholar 

  299. Tobian AAR, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360:1298–309.

    PubMed  CAS  PubMed Central  Google Scholar 

  300. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in orange farm, South Africa. J Infect Dis. 2009;199:958–64.

    PubMed  PubMed Central  Google Scholar 

  301. Tobian AAR, Kigozi G, Redd AD, et al. Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis. 2012;205:486–90.

    PubMed  PubMed Central  Google Scholar 

  302. Wald A. Knowledge is power: A case for wider herpes simplex virus serologic testing. JAMA Pediatrics. 2013;167:689–90.

    PubMed  Google Scholar 

  303. Screening for Genital Herpes: Recommendation Statement. AHRQ Publication No. 05-0573-A, March 2005. Available at: http://www.uspreventiveservicestaskforce.org/uspstf05/herpes/herpesrs.htm. Accessed 09/06, 2012.

  304. Ross K, Johnston C, Wald A. Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review. Sex Transm Infect. 2011;87:594–600.

    PubMed  Google Scholar 

Download references

Acknowledgment

The authors would like to acknowledge and thank Drs. Andre J. Nahmias and Daniel M. Jorgensen for their contributions to the previous versions of this chapter.

Author information

Authors and Affiliations

  1. Division of Allergy and Infectious Disease, University of Washington, Virology Research Clinic, 325 9th Ave, 359928, Seattle, WA, 98104, USA

    Christine Johnston MD, MPH

  2. Faculty Affairs Office, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, LE-500, 19024, Seattle, WA, 98109-1024, USA

    Rhoda Ashley Morrow PhD

  3. Department of Pediatrics, Columbia University College of Physicians and Surgeons, 630 West 168th Street, CHC-114, New York, NY, 10032, USA

    Lawrence R. Stanberry MD, PhD

Authors
  1. Christine Johnston MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rhoda Ashley Morrow PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lawrence R. Stanberry MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine Johnston MD, MPH .

Editor information

Editors and Affiliations

  1. Department of Epidemiology, University of Alabama, Birmingham School of Public Health, Birmingham, Alabama, USA

    Richard A. Kaslow

  2. Departmant of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA

    Lawrence R. Stanberry

  3. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA

    James W. Le Duc

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Johnston, C., Morrow, R.A., Stanberry, L.R. (2014). Human Herpesviruses: Herpes Simplex Virus Types 1 and 2. In: Kaslow, R., Stanberry, L., Le Duc, J. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7448-8_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7448-8_36

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7447-1

  • Online ISBN: 978-1-4899-7448-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation